Skip to content
Home/Companies/Pharma/Zevra Therapeutics
Zevra Therapeutics

Zevra Therapeutics

Pharma·United States·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Zevra Therapeutics?

Zevra Therapeutics is currently owned by TVM Capital Life Science through TVM Life Science Ventures (2004 vintage), since 2023.

Hand-verified · updated 2026-08-11

TVM Capital Life Science
Investor
TVM Capital Life Science
TVM Life Science Ventures · 2004 · VC

Key facts

HQUnited States
SectorPharma
StatusActive
Websitezevra.com

More from TVM Life Science Ventures

Other portfolio companies in the same fund.

CSA Medical, Inc.
Active
MedTechUnited States· 2024
Jacobian GmbH
Jacobian GmbH
Active
HealthTechGermany· 2024
Myosotis GmbH
Active
HealthTechGermany· 2024
Vektor Medical, Inc.
Active
MedTechUnited States· 2024
Egg Medical
Egg Medical
Active
MedTechUnited States· 2022
Nested Therapeutics
Nested Therapeutics
Active
BiotechUnited States· 2022

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Laboratoires Delbert
Active
SocadifFrance
AMW
AMW
Active
SHS Gesellschaft für BeteiligungsmanagementGermany· 2026
Basic Pharma
Active
SHS Gesellschaft für BeteiligungsmanagementNetherlands· 2026
Cinclus Pharma
Cinclus Pharma
Active
Claret Capital PartnersSweden· 2026
InfoRLife
Active
BC PartnersSwitzerland· 2026
IRAB
IRAB
Active
ARCHIMEDSpain· 2026
Track Zevra Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Zevra Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue